COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Study to Evaluate the Safety, Tolerance, and Pharmacokinetic and Pharmacodynamic Profile Of 1 SR Formulation of EB-1020

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01744808
Recruitment Status : Completed
First Posted : December 7, 2012
Last Update Posted : April 3, 2014
Information provided by (Responsible Party):
Euthymics BioScience, Inc. ( Neurovance, Inc. )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 2014
Actual Study Completion Date : February 2014